Literature DB >> 6608449

Activation and proliferation signals in mouse B cells. II. Evidence for activation (G0 to G1) signals differing in sensitivity to cyclosporine.

G G Klaus, C M Hawrylowicz.   

Abstract

We have previously shown that cyclosporine (CS) selectively inhibits polyclonal activation of B cells by anti-Ig antibodies but not by lipopolysaccharide (LPS). Here we extend these results using a two-stage B cell culture system in which cells from either CBA/N or normal mice are activated to enter G1 by anti-Ig, and are then stimulated to proliferate by LPS. In this system CS blocks an event that occurs within 4 h after initial activation, i.e. prevents entry of B cells into G1. Phorbol myristic acetate also induces some CBA/N B cells to enter G1. However, activation of B cells by this agent is resistant to inhibition by CS. These data suggest that there are two biochemically distinct mechanisms for driving resting B cells into G1. A hypothesis to explain these results is presented.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6608449     DOI: 10.1002/eji.1830140309

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

1.  Activation and proliferation signals in mouse B cells. VII. Calcium ionophores are non-mitogenic polyclonal B-cell activators.

Authors:  G G Klaus; M K Bijsterbosch; M Holman
Journal:  Immunology       Date:  1985-10       Impact factor: 7.397

2.  Evidence for a functional receptor for cyclosporin A on the surface of lymphocytes.

Authors:  N A Cacalano; B X Chen; W L Cleveland; B F Erlanger
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

Review 3.  The influence of cyclosporin A on cell-mediated immunity.

Authors:  A W Thomson; L M Webster
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

4.  Effect of cyclosporin A treatment on the production of antibody in insulin-dependent (type I) diabetic patients.

Authors:  C Boitard; G Feutren; L Castano; M Debray-Sachs; R Assan; J Hors; J F Bach
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

5.  Cyclosporine does not inhibit mitogen-induced inositol phospholipid degradation in mouse lymphocytes.

Authors:  M K Bijsterbosch; G G Klaus
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

6.  Recombinant IL-4 and IFN-gamma activate locomotor capacity in human B lymphocytes.

Authors:  P C Wilkinson; L N Islam
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

7.  Activation and proliferation signals in mouse B cells. IX. Protein kinase C activators synergize with non-mitogenic anti-immunoglobulin antibodies to drive B cells into G1.

Authors:  M K Bijsterbosch; J B McLaughlin; M Holman; G G Klaus
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

8.  Cyclosporin A inhibits mitogen-activated but not phorbol ester-activated locomotion of human lymphocytes.

Authors:  P C Wilkinson; A Higgins
Journal:  Immunology       Date:  1987-07       Impact factor: 7.397

9.  Cyclosporine facilitates B-cell membrane immunoglobulin capping.

Authors:  L Mosbach-Ozmen; S Humez; M Koponen; P Fonteneau; F Loor
Journal:  Immunology       Date:  1986-04       Impact factor: 7.397

10.  Cyclosporine inhibition of a murine B cell lymphoma.

Authors:  D S Pisetsky; G Haughton
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.